New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
16:38 EDTABCOThe Advisory Board sees CY13 adjusted EPS $1.18-$1.28
The Company provided financial guidance for calendar year 2013, which may not compare to consensus. For the calendar year, the company expects revenue to be in a range of approximately $495M-$505M, adjusted EBITDA $90M-$95M and non-GAAP EPS $1.18-$1.28. Consensus for FY14, ending March 2014, is $523.26M for revenue and $1.51 for EPS.
News For ABCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2015
07:12 EDTABCOWilliam Blair names 21 stocks best positioned for volatile markets
Subscribe for More Information
August 25, 2015
08:36 EDTABCOThe Advisory Board weakness has created 'great entry point,' says Oppenheimer
Oppenheimer believes that the recent weakness in The Advisory Board has created "a great entry point." The firm says that the execution of the company's recently acquired Royall unit will probably negatively impact The Advisory Board's results. However, the firm thinks that the company's core healthcare segment, which it says accounts for 80% of the company's revenues, "is doing very well." Oppenheimer keeps a $61 price target and Outperform rating on the shares.
August 24, 2015
07:08 EDTABCOThe Advisory Board outlook has improved, says SunTrust
Subscribe for More Information
August 17, 2015
09:14 EDTABCOThe Advisory Board upgraded to Outperform at Baird
Subscribe for More Information
06:46 EDTABCOThe Advisory Board upgraded to Outperform from Neutral at Baird
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use